Best Brain & Memory Supplements: Only 3 Have Real Evidence
Informational summary of published trials, not medical advice. Memory loss that interferes with daily life needs a clinician, not a supplement.
Quick answer
Three ingredients have trial evidence for memory, and each works for a specific person. Vitamin B12 if you test low: deficiency is the one fixable cause of memory loss, and supplementing when you are not low does nothing. Creatine monohydrate at 5 g/day for a small, real gain in memory tests; the two meta-analyses disagree on which ages benefit most, and vegetarians respond best. Omega-3 only if your fish intake is low and your memory is already slipping. The other seven, including the ones sold hardest as brain supplements, rest on one or two small trials each. Ginkgo was tested properly and failed.
The evidence-backed three cost $1.01/day from our catalog picks; all ten cost $6.91/day at the doses the trials used. The gap buys ingredients with no replicated result. See the cost table →
For daytime energy and focus rather than memory, see the energy and focus stack.
On this page
Ten brain supplements, ranked by the strength of their evidence
Ordered by the size and quality of the randomized trials, weighted toward people without dementia because that is who buys these products. Cost is our catalog pick at the dose the cited trial used.
| # | Ingredient | What the trials say | Studied dose | Our pick | Cost/day |
|---|---|---|---|---|---|
| 1 | Vitamin B12 | Certain if you are deficient; null in people with normal levels. | 1,000 mcg/day oral, if a test shows you are low | Nature Made Vitamin B12 1000 mcg Sublingual Fast Dissolve USP Verified | $0.11 |
| 2 | Creatine monohydrate | Small, real memory gain; the two reviews disagree on which ages benefit most; vegetarians respond best. | 5 g/day, every day | Optimum Nutrition Micronized Creatine Monohydrate (60 servings) Banned Substance Tested | $0.27 |
| 3 | Omega-3 (EPA/DHA) | Null in healthy older adults and in Alzheimer’s; a small signal in early decline. | 900 mg DHA/day (the one positive trial); 700 mg EPA+DHA was null | Sports Research Triple Strength Omega-3 (1250mg) 950 mg EPA+DHA per softgel, IFOS 5-Star, MSC Certified | $0.63 |
| 4 | Citicoline | One 100-person trial in age-related memory impairment, positive, manufacturer-run. | 500 mg/day | Life Extension Citicoline (Cognizin) 500 mg Cognizin, the trial material | $0.43 |
| 5 | Lion’s mane | One 30-person trial in mild cognitive impairment; effect gone 4 weeks after stopping. | 3 g/day dried fruiting body | Real Mushrooms Lion's Mane (120 Capsules) 1,000 mg per serving | $1.74 (3 servings) |
| 6 | Phosphatidylserine | FDA: "very limited and preliminary". The soy form failed its main trial. | 300 mg/day | Double Wood Phosphatidylserine 300mg | $0.33 |
| 7 | Magnesium L-threonate | One 44-person trial by the compound’s developer. Never replicated. | 1.5 to 2 g/day of Magtein | Life Extension Neuro-Mag Magnesium L-Threonate (90 Capsules) | $1.02 |
| 8 | Alpha-GPC | Positive only in Alzheimer’s at a prescription-style dose. No trial in healthy adults. | 1,200 mg/day | Double Wood Supplements Alpha-GPC 600 mg label per serving; discloses standardization | $1.34 (2 servings) |
| 9 | L-theanine | Attention for two hours with caffeine. Not a memory supplement. | 200 mg with 100 to 150 mg caffeine | NOW Foods L-Theanine 200mg with Inositol (120ct) | $0.18 |
| 10 | Ginkgo biloba | 3,069 adults, 6 years: no dementia prevention, no slower decline. | 120 mg EGb 761 twice daily | Not recommended. If you take it anyway, Nature's Way Ginkgold Advanced Ginkgo Extract (150 Tablets) is the trial extract (why). | $0.86 (2 servings) |
1. Vitamin B12: the only certain fix, and only if you are low
B12 deficiency causes memory impairment and confusion, and correcting it reverses them when caught early. No other supplement here has a comparable effect for the person it applies to, and that is more people with age. In CDC NHANES data, 6.0% of Americans 65 and over test deficient against 1.8% of adults 18 to 30, because the stomach acid that frees B12 from food declines with age; the NIH advises adults over 50 to get most of their B12 from fortified food or a supplement (NIH ODS fact sheet). Metformin and acid-reducing drugs lower it further.
In people with normal levels, B vitamins do nothing for cognition: a meta-analysis of 11 trials in 22,000 people found that lowering homocysteine with B vitamins had no effect on memory, speed, executive function or global cognition (Clarke 2014, PMID: 24965307). The exception is the VITACOG trial in mild cognitive impairment: 266 adults over 70 given folic acid, 0.5 mg B12 and B6 for two years had slower brain atrophy (Smith 2010, PMID: 20838622) and, when baseline homocysteine was above the median, better global cognition and episodic memory than placebo (de Jager 2012, PMID: 21780182). The first step is a blood test, not a bottle.
Our pick: Nature Made Vitamin B12 1000 mcg Sublingual Fast Dissolve $0.11/day, USP Verified; 1,000 mcg oral corrects a deficiency even when absorption is poor.
2. Creatine: the best trial record of any over-the-counter brain supplement
The brain runs on the same phosphocreatine buffer as muscle, and the trials are, for a supplement, unusually consistent. The first gave 45 young vegetarians 5 g/day for six weeks and found better working memory and reasoning scores (Rae 2003, PMID: 14561278). A systematic review of six trials in 281 healthy people found short-term memory and reasoning may improve, with vegetarians responding better than meat-eaters (Avgerinos 2018, PMID: 29704637). The meta-analyses put a number on it: across eight trials, creatine improved memory by a standardized mean difference of 0.29, concentrated in adults aged 66 to 76 (SMD 0.88) with essentially none in 11-to-31-year-olds (Prokopidis 2023, PMID: 35984306); a 2024 analysis of 16 trials and 492 adults found the same overall memory effect (SMD 0.31) at moderate certainty and no effect on overall cognition or executive function, but its subgroups favoured people aged 18 to 60, the reverse of the 2023 age pattern, and the 2023 analysis drew a published letter challenging its statistics (Xu 2024, PMID: 39070254). The memory effect is real and small; which ages get most of it is not settled.
An SMD of 0.3 is a small effect, and the older-adult figure rests on few, heterogeneous trials. It is also the largest positive, replicated result any product here can show in people without dementia, which is why creatine sits above omega-3. The dose is the muscle dose, 5 g/day, every day: no loading, no cycling, no premium form.
Our pick: Optimum Nutrition Micronized Creatine Monohydrate (60 servings) $0.27/day, 60 servings, Banned Substance Tested. The creatine for the brain guide goes through each trial.
3. Omega-3: works in a narrow window, and the window is not “healthy adult”
Omega-3 has the largest trials here after ginkgo, and most are negative. In cognitively healthy people over 60, the Cochrane review found no benefit on any cognitive test across three high-quality trials with 3,536 participants (Sydenham 2012, PMID: 22696350); the largest gave 867 healthy 70-to-79-year-olds 700 mg of EPA+DHA a day for two years with no difference on any outcome (Dangour 2010, PMID: 20410089). AREDS2 gave 1 g a day to 3,501 older adults for five years: no effect (Chew 2015, PMID: 26305649). In mild-to-moderate Alzheimer’s, the Cochrane review of three trials in 632 people found no effect on cognition, function or severity, at high certainty (Burckhardt 2016, PMID: 27063583).
Between those nulls is where the signal lives. A meta-analysis of ten trials found no memory effect in healthy or Alzheimer’s subjects but a small benefit for recall and processing speed in people with cognitive impairment short of dementia (Mazereeuw 2012, PMID: 22305186). The trial behind that gave 485 adults over 55 with memory complaints 900 mg/day of DHA for 24 weeks and found better learning and recognition memory (Yurko-Mauro 2010, PMID: 20434961); it was run by the DHA manufacturer. So: if you eat fish twice a week, omega-3 will not improve your memory. If you eat little fish and your memory is slipping, 700 to 1,000 mg of EPA+DHA a day is a cheap, well-tolerated bet with one positive trial behind it.
Our pick: Sports Research Triple Strength Omega-3 (1250mg) $0.63/day, priced at the catalog’s two-softgel clinical dose (1,900 mg EPA+DHA); one softgel is about $0.32 and carries 950 mg EPA+DHA, only 260 mg of it DHA, so reaching the 900 mg of DHA used in the one positive trial takes three to four softgels; the omega-3 for the brain guide covers EPA versus DHA.
The hopeful seven: one or two small trials each
Each has a positive trial; none has a replicated one in the population that buys it. Ordered by how close the best trial comes to a healthy adult reader.
4. Citicoline (CDP-choline)
The best-positioned trial of the seven: 100 adults aged 50 to 85 with age-associated memory impairment took 500 mg/day of Cognizin citicoline or placebo for 12 weeks, and the citicoline group improved more on episodic memory, a secondary outcome (Nakazaki 2021, PMID: 33978188). The trial was run by Kyowa Hakko, which makes Cognizin, and it stands alone. Our pick: Life Extension Citicoline (Cognizin) 500 mg $0.43/day, the trial dose and material.
5. Lion’s mane (Hericium erinaceus)
The trial everyone cites randomized 30 Japanese adults aged 50 to 80 with mild cognitive impairment to 3 g/day of dried mushroom powder or placebo for 16 weeks. The mushroom group scored higher on a dementia rating scale; four weeks after stopping, the scores had fallen back (Mori 2009, PMID: 18844328). A second small 12-week trial reported improvement on the MMSE (Saitsu 2019, PMID: 31413233). That is the human record. Most capsules carry 500 mg to 1 g, so 3 g means three servings and triple the sticker price. Our pick: Real Mushrooms Lion's Mane (120 Capsules), $0.58/day per serving, $1.74/day at the trial dose; the lion’s mane guide ranks the shelf by verified beta-glucan.
6. Phosphatidylserine (PS)
The one ingredient here with an FDA position. Its 2003 qualified health claim must say that “very limited and preliminary scientific research” supports it and that the FDA “concludes that there is little scientific evidence supporting this claim” (FDA qualified health claims). The positive trials used PS from cow brain (Crook 1991, PMID: 2027477). That material left the market with BSE, and the soy PS that replaced it failed its main trial, 120 older adults with memory complaints at 300 or 600 mg/day for 12 weeks (Jorissen 2001, PMID: 11842880); a 78-person Japanese trial found a gain only in a low-scoring subgroup (Kato-Kataoka 2010, PMID: 21103034). Our pick, if you try it: Double Wood Phosphatidylserine 300mg $0.33/day, the dose both soy trials used.
7. Magnesium L-threonate
Sold on one trial. Forty-four adults aged 50 to 70 with cognitive impairment took the compound (MMFS-01, later branded Magtein) or placebo for 12 weeks, and overall cognitive ability improved relative to placebo with a large effect size (Liu 2016, PMID: 26519439). The first author is at Neurocentria, which developed the compound; 23 people took the active arm, and nobody independent has replicated it since. Our pick: Life Extension Neuro-Mag Magnesium L-Threonate (90 Capsules) $1.02/day; the threonate versus glycinate comparison covers when the premium is worth paying.
8. Alpha-GPC (choline alfoscerate)
Alpha-GPC is a prescription drug in parts of Europe and Asia, and its evidence is prescription-shaped: 261 patients with mild-to-moderate Alzheimer’s took 400 mg three times a day or placebo for 180 days and improved on the ADAS-Cog and MMSE while the placebo group declined (De Jesus Moreno Moreno 2003, PMID: 12637119). There is no randomized trial in healthy adults. It is also often sold as a 50% powder, and most labels do not say whether the milligrams printed are the blend or the compound. Our pick: Double Wood Supplements Alpha-GPC $0.67/day per serving, the only product in our set that discloses its standardization; the alpha-GPC guide shows the gap product by product.
9. L-theanine
Ranked low because it is on the wrong page. Its evidence is for attention, with caffeine: a meta-analysis of 11 acute trials found moderate effects of caffeine plus theanine on alertness and attention-switching in the first two hours, with the caffeine dose mattering more than the theanine dose (Camfield 2014, PMID: 24946991). A four-week trial of theanine alone in 30 adults improved verbal fluency on some tests; two authors worked for the tablet supplier (Hidese 2019, PMID: 31623400). Nothing in the record is about memory. Our pick, for the caffeine pairing: NOW Foods L-Theanine 200mg with Inositol (120ct) $0.18/day; dose and ratio are on the caffeine page.
10. Ginkgo biloba
Last because it is the best-tested ingredient here and the test was negative. The Ginkgo Evaluation of Memory study randomized 3,069 adults aged 72 to 96 (the age range as reported in the study’s cognitive-decline paper, Snitz 2009) to 120 mg of the standardized EGb 761 extract twice daily or placebo for a median 6.1 years: dementia rates were 3.3 per 100 person-years on ginkgo and 2.9 on placebo (DeKosky 2008, PMID: 19017911), and no cognitive domain declined more slowly (Snitz 2009, PMID: 20040554). The French GuidAge trial of 2,854 adults with memory complaints, same extract and dose, five years, found no reduction in Alzheimer’s disease (Vellas 2012, PMID: 22959217). We do not recommend a ginkgo product; the ginkgo guide explains why only the EGb 761 extract counts as studied. The one narrow exception is treatment, not prevention: EGb 761 at 240 mg/day has trial support in diagnosed mild-to-moderate dementia, which our ginkgo guide covers; that is a clinician’s decision, not a supplement-aisle one.
What the two stacks cost: $1.01/day with evidence, $6.91/day without
This is the page’s one piece of original data: a day of our catalog pick for each ingredient, priced at the dose the cited trial used. The evidence-backed three come to $1.01/day, about $30 a month. The hopeful seven add $5.90/day. Buying everything a typical “brain stack” article recommends costs $6.91/day, about $207 a month, most of it on ingredients whose best trial has fewer than 50 people in it.
| Item | Value |
|---|---|
| Vitamin B12 | $0.11 |
| Creatine monohydrate | $0.27 |
| Omega-3 (EPA/DHA) | $0.63 |
| Citicoline | $0.43 |
| Lion’s mane | $1.74 |
| Phosphatidylserine | $0.33 |
| Magnesium L-threonate | $1.02 |
| Alpha-GPC | $1.34 |
| L-theanine | $0.18 |
| Ginkgo biloba | $0.86 |
Method: catalog price divided by servings per container, multiplied by the servings needed to reach the trial dose (3 for lion’s mane at 3 g/day, 2 for alpha-GPC at 1,200 mg/day, 2 for ginkgo at 240 mg/day; one for the rest). Picks are the products we would buy in each category on certification, disclosed dose and price, not the cheapest listing. This is a catalog comparison, not a label census. What it cannot tell you: whether a cheaper product would serve you as well, or what any product costs today at checkout.
Memory supplements for seniors: correct the deficiencies before buying anything else
Look first for causes that reverse. B12 is the clearest: deficiency rises to 6.0% of Americans 65 and over, it mimics early dementia, and a blood test and a 1,000 mcg tablet fix it. Low vitamin D, thyroid disease, sleep apnea, depression and the anticholinergic load of common drugs belong on the same list, and a clinician can check all of them in one visit. The B12 for seniors and vitamin D for seniors guides cover the two supplements on that list.
Once deficiencies are excluded, two things remain. Creatine’s memory effect was largest in this group in one meta-analysis and in younger adults in the other, so treat it as a small, possible gain rather than a targeted one. And a plain daily multivitamin has a result none of the specialist brain products can match: in COSMOS-Mind, 2,262 adults with a mean age of 73 who took a standard multivitamin for three years had better global cognition and memory than placebo (Baker 2023, PMID: 36102337), and a meta-analysis across the three COSMOS cognitive substudies put the effect at roughly two years less cognitive aging (Vyas 2024, PMID: 38244989). The effect is modest and the mechanism unknown, but it is a large, independent, replicated result, which none of the hopeful seven can say.
What actually moves the risk, and none of it comes in a capsule
The Lancet Commission on dementia named 12 modifiable risk factors in 2020 that account for around 40% of cases (Livingston 2020, PMID: 32738937) and added high LDL cholesterol and untreated vision loss in 2024, for around 45% (Livingston 2024, PMID: 39096926). No supplement is on the list; hearing loss, high blood pressure, inactivity, smoking, diabetes, obesity and depression are.
Three have randomized trials of the kind supplements lack. In SPRINT MIND, 9,361 adults with hypertension treated to a systolic target of 120 rather than 140 mmHg had 19% less mild cognitive impairment over five years (SPRINT MIND 2019, PMID: 30688979). In ACHIEVE, 977 adults aged 70 to 84 with untreated hearing loss were randomized to hearing aids or health education; decline slowed in the prespecified higher-risk subgroup, though not in the whole cohort (Lin 2023, PMID: 37478886). A meta-analysis of 39 randomized exercise trials in adults over 50 found aerobic, resistance and multicomponent exercise all improved cognition, pooled effect 0.29, the same size as creatine’s (Northey 2018, PMID: 28438770). Against that, the Cochrane verdict on supplements in cognitively healthy adults is blunt: across 28 studies and more than 83,000 people, no vitamin or mineral meaningfully affected cognitive decline or dementia (Rutjes 2018, PMID: 30556597), and the AHRQ review found the evidence insufficient to recommend any over-the-counter supplement (Butler 2018, PMID: 29255909). The order: blood pressure, hearing, exercise, sleep, then the three supplements above, then nothing.
The product links below go to Amazon and we may earn a commission if you buy. It never changes which products we pick or what we say about them. How we choose.
The evidence-backed three, $1.01/day (about $30/month): Nature Made Vitamin B12 1000 mcg Sublingual Fast Dissolve $0.11/day if a blood test says you are low, plus Optimum Nutrition Micronized Creatine Monohydrate (60 servings) $0.27/day at 5 g every day, plus Sports Research Triple Strength Omega-3 (1250mg) $0.63/day if your fish intake is low. Creatine is the one that applies to nearly everyone.
Frequently asked questions
What is the best supplement for memory?
It depends on what is wrong. If your B12 is low, correcting it is the only supplement change with a certain effect on memory, at $0.11/day. Otherwise creatine monohydrate at 5 g/day has the best trial record of any over-the-counter ingredient: a small, real gain in memory tests, largest in adults over 65 and in vegetarians. Omega-3 helps only if fish intake is low and memory is already slipping. Nothing else here has more than one or two small trials behind it.
Do brain supplements actually work?
Mostly no, for people whose brains work normally. The Cochrane review of vitamin and mineral supplements in cognitively healthy adults (28 studies, more than 83,000 people) found none that protects cognition, and the AHRQ review of over-the-counter supplements agreed. The exceptions: correcting a real B12 deficiency, creatine in older adults and vegetarians, and a plain daily multivitamin in the COSMOS trials. The ingredients marketed hardest for memory rest on one or two small trials each, often run by the maker.
What are the best brain supplements for students?
For attention during study, caffeine plus L-theanine has consistent acute trial results: better alertness and attention-switching for two hours, driven more by the caffeine. It is not a memory supplement. For memory, creatine is the only ingredient with a positive randomized result in young adults, and that result came from vegetarians. Sleep, spaced practice and exercise beat every product on this page for exams.
What are the best memory supplements for seniors?
Start with the deficiencies that mimic memory loss. B12 deficiency rises with age (6.0% of Americans 65 and over test deficient against 1.8% of 18-to-30-year-olds) and is reversible; rule out low vitamin D and thyroid problems at the same time. After that: creatine, a small memory effect whose age pattern differs between the two meta-analyses, and a plain multivitamin, which slowed cognitive aging by about two years in the COSMOS trials. Hearing aids, blood-pressure control and exercise each have better trial evidence than any memory supplement.
Lion’s mane vs citicoline vs alpha-GPC: which is better for memory?
Citicoline has the largest recent trial in people without dementia: 100 adults aged 50 to 85 with age-associated memory impairment, 500 mg/day for 12 weeks, better episodic memory than placebo, manufacturer-run. Lion’s mane has a 30-person, 16-week trial in mild cognitive impairment whose gains faded within four weeks of stopping. Alpha-GPC’s only evidence is a 2003 Alzheimer’s trial at 1,200 mg/day. None has been replicated at scale.
When should I see a doctor about memory problems?
When lapses interfere with daily life, when others notice them before you do, when they arrive over months rather than years, or when they come with confusion, mood change or a new medication. A clinician can test the reversible causes (B12, thyroid, vitamin D, depression, sleep apnea, drug interactions) and refer for a cognitive assessment. Nothing on this page should delay that, and nothing on it treats dementia.
Related guides
- Best lion’s mane supplement: ranked by verified beta-glucan
- Best omega-3 overall: IFOS-verified picks by cost per gram
- B12 for seniors: testing, dosing, drug interactions
- Creatine for seniors: dose and safety after 65
- Magnesium L-threonate vs glycinate: when the premium is worth it
- Energy and focus stack: daytime focus, a different question
- Supplement stack for adults over 50: D3, B12, CoQ10, omega-3
Sources
- NIH Office of Dietary Supplements. "Vitamin B12: Fact Sheet for Health Professionals." ods.od.nih.gov
- Clarke R, et al. "Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals." Am J Clin Nutr. 2014. PMID: 24965307
- Smith AD, et al. "Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial." PLoS One. 2010. PMID: 20838622
- de Jager CA, et al. "Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial." Int J Geriatr Psychiatry. 2012. PMID: 21780182
- Rae C, et al. "Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial." Proc Biol Sci. 2003. PMID: 14561278
- Avgerinos KI, et al. "Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials." Exp Gerontol. 2018. PMID: 29704637
- Prokopidis K, et al. "Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials." Nutr Rev. 2023. PMID: 35984306
- Xu C, et al. "The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis." Front Nutr. 2024. PMID: 39070254
- Sydenham E, et al. "Omega 3 fatty acid for the prevention of cognitive decline and dementia." Cochrane Database Syst Rev. 2012. PMID: 22696350
- Dangour AD, et al. "Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial." Am J Clin Nutr. 2010. PMID: 20410089
- Chew EY, et al. "Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial." JAMA. 2015. PMID: 26305649
- Burckhardt M, et al. "Omega-3 fatty acids for the treatment of dementia." Cochrane Database Syst Rev. 2016. PMID: 27063583
- Mazereeuw G, et al. "Effects of ω-3 fatty acids on cognitive performance: a meta-analysis." Neurobiol Aging. 2012. PMID: 22305186
- Yurko-Mauro K, et al. "Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline." Alzheimers Dement. 2010. PMID: 20434961
- Nakazaki E, et al. "Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial." J Nutr. 2021. PMID: 33978188
- Mori K, et al. "Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial." Phytother Res. 2009. PMID: 18844328
- Saitsu Y, et al. "Improvement of cognitive functions by oral intake of Hericium erinaceus." Biomed Res. 2019. PMID: 31413233
- US Food and Drug Administration. "Qualified Health Claims: Letters of Enforcement Discretion" (phosphatidylserine and cognitive dysfunction and dementia, 2003). fda.gov
- Crook TH, et al. "Effects of phosphatidylserine in age-associated memory impairment." Neurology. 1991. PMID: 2027477
- Jorissen BL, et al. "The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment." Nutr Neurosci. 2001. PMID: 11842880
- Kato-Kataoka A, et al. "Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints." J Clin Biochem Nutr. 2010. PMID: 21103034
- Liu G, et al. "Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial." J Alzheimers Dis. 2016. PMID: 26519439
- De Jesus Moreno Moreno M. "Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial." Clin Ther. 2003. PMID: 12637119
- Camfield DA, et al. "Acute effects of tea constituents L-theanine, caffeine, and epigallocatechin gallate on cognitive function and mood: a systematic review and meta-analysis." Nutr Rev. 2014. PMID: 24946991
- Hidese S, et al. "Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial." Nutrients. 2019. PMID: 31623400
- DeKosky ST, et al. "Ginkgo biloba for prevention of dementia: a randomized controlled trial." JAMA. 2008. PMID: 19017911
- Snitz BE, et al. "Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial." JAMA. 2009. PMID: 20040554
- Vellas B, et al. "Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial." Lancet Neurol. 2012. PMID: 22959217
- Baker LD, et al. "Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial." Alzheimers Dement. 2023. PMID: 36102337
- Vyas CM, et al. "Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COSMOS randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS." Am J Clin Nutr. 2024. PMID: 38244989
- Rutjes AW, et al. "Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life." Cochrane Database Syst Rev. 2018. PMID: 30556597
- Butler M, et al. "Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review." Ann Intern Med. 2018. PMID: 29255909
- Livingston G, et al. "Dementia prevention, intervention, and care: 2020 report of the Lancet Commission." Lancet. 2020. PMID: 32738937
- Livingston G, et al. "Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission." Lancet. 2024. PMID: 39096926
- SPRINT MIND Investigators for the SPRINT Research Group. "Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial." JAMA. 2019. PMID: 30688979
- Lin FR, et al. "Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial." Lancet. 2023. PMID: 37478886
- Northey JM, et al. "Exercise interventions for cognitive function in adults older than 50: a systematic review with meta-analysis." Br J Sports Med. 2018. PMID: 28438770
- CDC National Health and Nutrition Examination Survey, serum vitamin B12 by age; see deficiency statistics for the data module and its citation.